Evidence map›Paper›PMID 42101024›Full record

ArticleChemSusChem2026

Sustainable Syntheses of p-Hydroxycinnamic-Based Macrobisphenols: Progress, Challenges, and Comparative Assessment of Yield and Sustainability.

Amandine L Flourat, Damien Breilly, Floriane Rischard, Aurélien A M Péru, Rémi Estorges, Abdouramane Dosso, Sami Fadlallah, Antoine Gallos, Florent Allais

Abstract read
In one paragraph

Article in ChemSusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Amandine L FlouratURD Agro-Biotechnologies Industrielles (ABI), AgroParisTech, Pomacle, France.ORCID https://orcid.org/0000-0001-5692-7786
Damien BreillyURD Agro-Biotechnologies Industrielles (ABI), AgroParisTech, Pomacle, France.
Floriane RischardURD Agro-Biotechnologies Industrielles (ABI), AgroParisTech, Pomacle, France.
Aurélien A M PéruURD Agro-Biotechnologies Industrielles (ABI), AgroParisTech, Pomacle, France.
Rémi EstorgesURD Agro-Biotechnologies Industrielles (ABI), AgroParisTech, Pomacle, France.
Abdouramane DossoURD Agro-Biotechnologies Industrielles (ABI), AgroParisTech, Pomacle, France.
Sami FadlallahURD Agro-Biotechnologies Industrielles (ABI), AgroParisTech, Pomacle, France.ORCID https://orcid.org/0000-0002-7936-8195
Antoine GallosURD Agro-Biotechnologies Industrielles (ABI), AgroParisTech, Pomacle, France.
Florent AllaisURD Agro-Biotechnologies Industrielles (ABI), AgroParisTech, Pomacle, France.ORCID https://orcid.org/0000-0003-4132-6210

Funding

Agence Nationale de la Recherche (ANR) ANR-21-CE19-0055
6 · The paper itself

Abstract

Macrobisphenols are a family of bio-inspired bisphenols introduced in 2013, composed of two p-hydroxycinnamate units linked through ester bonds via a polyol scaffold. Unlike bisphenol A, macrobisphenols are non-endocrine-disrupting compounds, and display outstanding antiradical activity, making them attractive, safer alternatives for polymer-related applications. Their versatility enables use as plasticizers, antioxidants, and monomers for polymer and materials synthesis. Over the past 12 years, substantial progress has been made to enhance their industrial viability by expanding structural diversity through extensive libraries of analogs, significantly lowering production costs, and minimizing environmental impact through greener synthetic strategies. This article critically reviews the evolution of macrobisphenol synthesis, highlights recent advances in sustainable and scalable pathways, and provides practical guidelines for selecting the most cost-effective and environmentally responsible processes according to the targeted structure.

Indexed as

bisphenolgreen chemistryp‐hydroxycinnamic acidsscalabilitytunability

Identifiers

PMID42101024
PMCPMC13154719

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.